Home - Products - Angiogenesis - IGF-1R - LMPTP INHIBITOR 1 hydrochloride (1908414-82-3(free base))

LMPTP INHIBITOR 1 hydrochloride (1908414-82-3(free base))

CAS No. ——

LMPTP INHIBITOR 1 hydrochloride (1908414-82-3(free base))( —— )

Catalog No. M19315 CAS No. ——

LMPTP INHIBITOR 1 is a selective inhibitor of low molecular weight protein tyrosine phosphatase (LMPTP), with an IC50 of 0.8 μM LMPTP-A.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 298 Get Quote
10MG 470 Get Quote
25MG 658 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    LMPTP INHIBITOR 1 hydrochloride (1908414-82-3(free base))
  • Note
    Research use only, not for human use.
  • Brief Description
    LMPTP INHIBITOR 1 is a selective inhibitor of low molecular weight protein tyrosine phosphatase (LMPTP), with an IC50 of 0.8 μM LMPTP-A.
  • Description
    LMPTP INHIBITOR 1 is a selective inhibitor of low molecular weight protein tyrosine phosphatase (LMPTP), with an IC50 of 0.8 μM LMPTP-A.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    IGF-1R
  • Recptor
    LMPTP-A
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    ——
  • Formula Weight
    481.07
  • Molecular Formula
    C28H37ClN4O
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    Cl.Cl.CCN(CC)C(=O)c1ccc(cc1)c3nc2ccccc2c(c3)NCCCN4CCCCC4
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Stanford SM1, et al. Diabetes reversal by inhibition of the low-molecular-weight tyrosine phosphatase. Nat Chem Biol. 2017 Jun;13(6):624-632.
molnova catalog
related products
  • AZ7550 trimesylate s...

    AZ7550 trimesylate salt (AZ7550 Mesylate) is the active metabolite of ositinib, AZ7550 trimesylate salt inhibits IGF1R activity and can be used in the study of non-small cell lung cancer.

  • CTLA-4 inhibitor

    CTLA-4 inhibitor is a potent CTLA-4 inhibitor.

  • NT157

    NT157 is a small molecule tyrphostin targeting IRS protein and has the potential to inhibit IGF-1R and STAT3 signaling pathways in TME cancer cells and stromal cells, resulting in decreased cancer cell survival.